Portola Pharmaceuticals, Inc.
PTLA
PTLA was delisted on the 1st of July, 2020.
0 hedge funds and large institutions have $0 invested in Portola Pharmaceuticals, Inc. in 2020 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 162 closing their positions.
100% less funds holding
Funds holding: 162 → 0 (-162)
100% less funds holding in top 10
Funds holding in top 10: 12 → 0 (-12)
100% less capital invested
Capital invested by funds: $1.34B → $0 (-$1.34B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 162
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$126M |
| 2 |
BlackRock
New York
|
-$115M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$72.3M |
| 4 |
Goldman Sachs
New York
|
-$64.6M |
| 5 |
State Street
Boston,
Massachusetts
|
-$63.3M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1IA
151
1834 Investment Advisors
Milwaukee,
Wisconsin
| – | -$4K | -243 | Closed |
|
152
Rockefeller Capital Management
New York
| – | -$4K | -219 | Closed |
|
|
SPIA
153
Steward Partners Investment Advisory
New York
| – | -$2K | -100 | Closed |
|
|
APA
154
American Portfolios Advisors
Holbrook,
New York
| – | -$1.75K | -97 | Closed |
|
|
LC
155
Lindbrook Capital
Calabasas,
California
| – | -$2K | -90 | Closed |
|
156
AssetMark Inc
Concord,
California
| – | -$1K | -73 | Closed |
|
|
LFG
157
Larson Financial Group
St Louis,
Missouri
| – | -$1K | -51 | Closed |
|
|
CFN
158
Cordasco Financial Network
Naples,
Florida
| – | -$1K | -50 | Closed |
|
|
OSAM
159
O'Shaughnessy Asset Management
Stamford,
Connecticut
| – | -$1K | -49 | Closed |
|
PTLA Hedge Fund Activity: Q3 2020 in Review
0 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Portola Pharmaceuticals, Inc. (PTLA) for Q3 2020, worth a combined $0 — down 100% from $1.34B a quarter earlier.
Sellers outnumbered buyers: 162 funds closed out of PTLA and 0 opened new positions — a net loss of 162 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Vanguard Group, exiting entirely with an estimated $126M sold.
- 0 institutional investors held Portola Pharmaceuticals, Inc. (PTLA) as of Q3 2020, down from 162 in Q2 2020.
- Funds reported $0 of Portola Pharmaceuticals, Inc. stock for Q3 2020, down 100% quarter-over-quarter.
- 0 funds opened new Portola Pharmaceuticals, Inc. positions in Q3 2020 and 162 closed out, a net change of -162 holders.
- The largest Portola Pharmaceuticals, Inc. seller in Q3 2020 was Vanguard Group, an estimated $126M sold.
Based on aggregated 13F filings for Q3 2020.